FindTrial
Sign In

A Novel Herbal Dermatology Blend for Clearer Skin in Acne

A multi-action anti acne formulation using Tretinoin, Niacinamide, Zinc and Azadirachta Indica. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094900
Enrollment
75
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Anti acne cream with Tretinoin, Niacinamide, Zinc and Azadirachta Indica: A topical cream of Tretinoin 0.05%, Niacinamide 5%, Zinc PCA 1%, Azadirachta Indica 3% - topical application fo

Sponsors

Dr. Palchuri Sneha Ananya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mild to moderate acne vulgaris based on clinical diagnosis. 2. Willingness to comply with study procedures and provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women 2. Severe nodular or cystic acne requiring systemic treatment. 3. Use of systemic Retinoids, Corticosteroids, or other acne treatments in past 5 months that could affect study outcomes. 4. Known allergies or sensitivity to any ingredientsin the study formulation. 5. Unwilling to comply with study procedures.

Design outcomes

Primary

MeasureTime frame
Reduction in lesion count, change in acne severity scoreTimepoint: 3 months—

Secondary

MeasureTime frame
Tolerability and safety profileTimepoint: 3 months—

Countries

India

Contacts

Public ContactPalchuri Sneha Ananya

Saveetha medical college and hospital, Saveetha institute of medical and technical sciences.

Sneha2000Reddy@gmail.com9715686909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026